Table 5.
Observed adverse events according to common terminology criteria for adverse events grading, n (%)
| Adverse event | TACE/HAIC + S-1, n = 55 | TACE/HAIC, n = 60 | P value |
| Liver injury | 0.243 | ||
| Grades 1-2 | 28 (50.9) | 23 (38.3) | |
| Grades 3-4 | 27 (49.1) | 37 (61.7) | |
| Vomiting | 0.478 | ||
| Grades 1-2 | 23 (41.8) | 29 (48.3) | |
| Grades 3-4 | 1 (1.8) | 0 (0) | |
| Abdominal pain | 0.820 | ||
| Grades 1-2 | 37 (67.3) | 37 (61.7) | |
| Grades 3-4 | 10 (18.2) | 13 (21.7) | |
| Fever | 0.277 | ||
| Grades 1-2 | 45 (81.8) | 44 (73.3) | |
| Grades 3-4 | 0 (0) | 0 (0) | |
| Leukopenia | 0.465 | ||
| Grades 1 | 2 (3.6) | 4 (6.7) | |
| Grades 2-4 | 0 (0) | 0 (0) | |
| Thrombocytopenia | 0.793 | ||
| Grade 1 | 9 (16.4) | 11 (18.3) | |
| Grade 2 | 7 (12.7) | 7 (11.7) | |
| Grade 3 | 0 (0) | 1 (1.7) | |
| Grade 4 | 0 (0) | 0 (0) | |
| Anemia | 0.220 | ||
| Grade 1 | 7 (12.7) | 15 (25.0) | |
| Grade 2 | 2 (3.6) | 5 (8.3) | |
| Grade 3 | 1 (1.8) | 1 (1.7) | |
| Grade 4 | 0 (0) | 0 (0) |
HAIC: Hepatic arterial infusion chemotherapy; TACE: Transarterial chemoembolization.